Cannabis use is prevalent but only a minority of regular users develop cannabis use disorder (CUD); thus, CUD risk identification among current cannabis users is vital for targeted intervention development. Existing data suggest that high distress intolerance (DI), an individual difference reflective of the ability to withstand negative affect, is linked to CUD, possibly via stress-elicited impairment of response inhibition but this has never been explicitly tested. Frequent cannabis users with high and low DI completed a go/no-go task during EEG recording before and after a laboratory stressor. Relations between DI, cannabis use-related problems, and behavioral as well as neurophysiological markers of response inhibition functioning were assessed. DI significantly moderated the effect of the stressor on the conflict-monitoring but not evaluative phase of response inhibition as measured by N2 and P3a amplitude, respectively. Unexpectedly, cannabis users with high DI demonstrated stressor-elicited enhancement rather than impairment of conflict-monitoring neural activity, which was related to faster reaction time (RT) and decreased past-month cannabis problems. Enhanced inhibition-related modulation of P3a amplitude was generally associated with increased cannabis problems regardless of acute stress. Results did not provide support for stress-elicited impairment in cognitive control as a mechanism linking high DI and CUD, though some support was found for the relevance of inhibition-related neural activity to CUD. Stress-elicited enhancement of conflict-monitoring neural activity during response inhibition may reflect an adaptive neural response among cannabis users with high DI that protects against CUD in this at-risk group.
The prevalence of cannabis use and cannabis use disorder (CUD) has increased in the United States over the past 20 years (Hasin et al., 2015) . Further, increases in cannabis use and CUD have been found in states with medical marijuana laws (Hasin et al., 2017) , suggesting that cannabis use prevalence is likely to continue increasing given changes in cultural acceptance and legalization of cannabis in the United States. Although most users do not develop CUD (Cougle, Hakes, Macatee, Zvolensky, & Chavarria, 2016) , national surveys from 2012-2013 suggest the lifetime prevalence of DSM-5 CUD is 6.3% (Hasin et al., 2016) . Given the disability associated with CUD (Hasin et al., 2016) , it is imperative to identify mechanisms that increase risk of CUD among current users to guide targeted intervention development.
Distress intolerance (DI) is an individual difference variable reflective of the actual or perceived capacity to tolerate negative emotional states, with behavioral (i.e., persistence time on a distressing task; Kiselica, Rojas, Bornovalova, & Dube, 2015) and self-report (i.e., perceived tolerability of negative affect and propensity for escape behavior; McHugh & Otto, 2012 ) measures used to assess actual and perceived DI, respectively. Despite conceptual overlap among behavioral and self-report measures of DI, they generally do not correlate with one another (e.g., Kiselica et al., 2015; McHugh et al., 2011) and have demonstrated differential relations with CUD-related phenomena (e.g., Hasan, Babson, Banducci, & Bonn-Miller, 2015) . Recent studies have dem-onstrated that high perceived DI is linked with increased cannabis use-related problems in regular users (Bujarski, Norberg, & Copeland, 2012; Farris, Metrik, Bonn-Miller, Kahler, & Zvolensky, 2016) . In addition, these associations appear to be partially mediated by increased coping motives for cannabis use (i.e., using cannabis to reduce negative affect), motives that have been linked with increased risk of developing CUD among regular users (van der Pol et al., 2013) . Further, high perceived DI and related phenomena (i.e., low perceived self-efficacy for resisting cannabis use while emotionally distressed) have also been linked with poorer CUD treatment outcome (Gullo, Matveeva, Feeney, Young, & Connor, 2017) and greater cannabis use during a self-guided quit attempt (Hasan et al., 2015) , underscoring the clinical relevance of perceived DI. However, little research on perceived DI's constituent mechanisms and neurobiological referents exist, hampering understanding of the construct and cross-discipline translation of research findings. Trafton and Gifford (2011) proposed that the ability to tolerate negative affect depends to some extent on cognitive control functioning in the context of acute stress. Specifically, Trafton and Gifford (2011) theorized that individual differences in DI partially reflect variability in response inhibition capacity such that refraining from stress-elicited escape behavior requires inhibition of prepotent but maladaptive responses, an ability that depends upon the cognitive control network in the brain spanning prefrontal, dorsal anterior cingulate, and parietal cortices (Niendam et al., 2012) . Electroencephalography (EEG) methods have revealed that response inhibition is composed of at least two distinct neural processes: (a) the ability to detect the need to withhold a response (i.e., conflict-monitoring reflected by the N2 component); and (b) the ability to act on the conflict signal with actual motor suppression (i.e., motor inhibition finalization/evaluation reflected by the P3a component; Huster, Enriquez-Geppert, Lavallee, Falkenstein, & Herrmann, 2013) . Although perceived DI's relationship with response inhibition under stress has not been explicitly tested, a recent study using the go/no-go task found an association between high perceived DI and the N2 but not P3a component . Specifically, greater perceived DI was associated with greater blunting (i.e., less negative) of N2 amplitude across trial types (i.e., no-go and go trials) which PCA revealed was attributable to a larger latent positivity factor (i.e., P2 factor). The association between enhanced latent P2 factor and slower go trial RT suggests that individuals with higher perceived DI utilize greater cognitive resources to resolve conflict during a response inhibition task without improvements in performance. In taxing circumstances such as acute stress, inefficiency of premotor response conflict-monitoring and its resolution (i.e., blunted N2 amplitude/enhanced latent P2 factor) could result in downstream impairment of response inhibition, ultimately resulting in decreased capacity to restrain cannabis use.
Existing data provides some support for an association between response inhibition and CUD, but findings are mixed. Worse response inhibition task performance has been found in problem cannabis users relative to healthy controls (Behan et al., 2014; Maij, van de Wetering, & Franken, 2017; Moreno et al., 2012) , though nonsignificant group differences have also been reported (Crane, Schuster, & Gonzalez, 2013; Dougherty et al., 2013; Gonzalez et al., 2012; Grant, Chamberlain, Schreiber, & Odlaug, 2012; Hester, Nestor, & Garavan, 2009; Smith et al., 2011; Tapert et al., 2007) . Response inhibitionrelated neural activity's association with cannabis use is similarly mixed. Increased activation (Hester et al., 2009; Smith et al., 2011; Tapert et al., 2007) , reduced activation (Maij et al., 2017) , and no group differences (Behan et al., 2014) in inhibitionrelated processing between cannabis users and healthy controls have been reported. However, studies reporting increased inhibition-related neural activity in cannabis users have also found no group differences in performance, whereas studies reporting decreased activation (Maij et al., 2017) or null group differences (Behan et al., 2014 ) did find worse behavioral performance, a pattern of findings suggestive of inefficient inhibition-related processing in cannabis users (i.e., greater activation required for normative performance) and in line with Macatee et al.'s (2018) interpretation of perceived DI's association with the N2 component. Overall, extant findings are mixed but largely suggest more consistent associations between cannabis use and altered inhibition-related neural activity rather than behavior. However, discrepant reports of increased (i.e., inefficient) versus decreased (i.e., impaired) activity suggests the presence of moderating variables. Given that high perceived DI is an established risk marker for CUD (Bujarski et al., 2012; Farris et al., 2016) and has been linked with inhibition-related conflict-monitoring neural activity , perceived DI may be relevant to the relationship between response inhibition and CUD.
Although provided preliminary support for an association between high perceived DI and inefficient inhibition-related conflict-monitoring neural activity (i.e., blunted N2 component/enhanced latent P2 factor), a stress induction was not utilized, a significant limitation given that the association between perceived DI and response inhibition should theoretically be most pronounced in the context of acute stress (Trafton & Gifford, 2011) . In healthy samples, acute stress has been linked with improved response inhibition task performance (Shields, Sazma, & Yonelinas, 2016) and enhanced ⌬N2 (i.e., more negative N2 amplitude on no-go relative to go trials; Dierolf, Fechtner, Böhnke, Wolf, & Naumann, 2017; Qi, Gao, & Liu, 2017) , with some evidence suggesting that stressor-elicited blunting of the ⌬P3a (i.e., less positive P3a amplitude on no-go relative go trials) may depend upon the degree of stressor reactivity. Measuring behavior as well as ⌬N2 and ⌬P3a during a response inhibition task before and after a laboratory stressor should allow for a better test of stress-elicited alteration of response inhibition as a mechanism linking perceived DI and CUD. Toward this end, regular cannabis users with high and low perceived DI were recruited and completed a go/no-go task before and after a laboratory stressor while EEG was recorded. We predicted that (a) compared with cannabis users with low perceived DI, those with high perceived DI will demonstrate a more blunted prestressor N2 across no-go and go trials , but will also demonstrate worse poststressor inhibition performance as well as a more blunted poststressor ⌬N2 and ⌬P3a. Further, we predicted that (b) stress-elicited inhibition performance, ⌬N2, and ⌬P3a will mediate the relationship between perceived DI and CUD severity. This document is copyrighted by the American Psychological Association or one of its allied publishers.
This article is intended solely for the personal use of the individual user and is not to be disseminated broadly.
Method Participants
Regular cannabis users (i.e., Ն twice per week for at least 1 year) between 18-and 30-years-old with high (i.e., Ն20) and low (i.e., Յ6) scores on the Distress Intolerance Index (DII; McHugh & Otto, 2012) , a self-report measure of DI, were recruited from the psychology student subject pool at a large southeastern university as well as the surrounding community (N ϭ 107); participants were offered course credit or monetary compensation for study completion. Cannabis users with high perceived DI were recruited as part of a larger randomized controlled trial (RCT) evaluating the efficacy of a computerized DI treatment in regular cannabis users reporting difficulty managing negative emotions; the high perceived DI group's baseline data were used in the present study. Among the 489 individuals who were screened for participation in the larger RCT, 63 cannabis users with high perceived DI were enrolled. Low perceived DI users were recruited as a matched comparison group on age, cannabis use frequency, and sex; low perceived DI users only attended the baseline appointment. Among the 620 individuals screened for the comparison group study, 44 low perceived DI users were enrolled. Participants were interviewed and excluded if they endorsed history of psychotic symptoms, current suicidal intent, or met criteria for bipolar disorder and were not stabilized on medication for at least 4 weeks. Additional exclusion criteria for the high perceived DI group included concurrent psychotherapy for stress/substance use and change in psychotropic medication in the past month.
Measures
Distress Intolerance Index. The DII is a 10-item self-report measure designed to assess individual differences in the perceived ability to tolerate distress (McHugh & Otto, 2012) . Respondents are asked to rate the extent to which they agree with each statement on a 0 to 4 scale (0 ϭ not at all, 1 ϭ a little, 2 ϭ some, 3 ϭ much, 4 ϭ very much). The DII has demonstrated good test-retest reliability (Çakır, 2016) , internal consistency (Çakır, 2016; McHugh & Otto, 2011; Szuhany & Otto, 2015) , and convergent validity with behavioral DI measures (McHugh & Otto, 2011; McHugh et al., 2016; Seo & Kwon, 2016; Szuhany & Otto, 2015 ; but see Williams, Vik, & Wong, 2015) . Cut-off scores for high (Ն20) and low perceived DI (Յ6) were determined based on mean/median scores in treatment-seeking samples McHugh et al., 2014) and the bottom quartile score in a nonclinical young adult sample (Macatee, Albanese, Allan, Schmidt, & Cougle, 2016) , respectively. Internal consistency was excellent in the combined high and low perceived DI screening sample (␣ ϭ .95) .
Cannabis use problems. Self-reported and interviewerassessed cannabis problem severity were used as outcome variables in the present study. Self-reported cannabis problem severity over the past month was assessed with the Marijuana Problems Scale (MPS; Stephens, Roffman, & Curtin, 2000) , a 19-item measure in which respondents rate the degree to which they have experienced each of 19 cannabis use-related problems over the past month on a 0 to 2 scale (0 ϭ no problem, 1 ϭ minor problem, 2 ϭ serious problem). The MPS has demonstrated good psychometric properties in prior work (Buckner, Keough, & Schmidt, 2007; ␣ ϭ .86 ) and the present study (␣ ϭ .83; r ϭ .68, p Ͻ .001 with past-year CUD criteria). Lifetime and past year CUD criteria were assessed using the substance use disorder module of the SCID-5-RV (First, Williams, Karg, & Spitzer, 2015) ; number of CUD criteria met in the past year was used to operationalize interviewer-assessed past year CUD severity. Interviews were administered by a doctoral-level graduate student and a postbaccalaureate research assistant. The research assistant received extensive diagnostic training involving didactics, role plays, and scoring recorded interviews until 100% agreement was achieved on three consecutive interviews. In the current study, a subsample of subjects (n ϭ 17) were used for reliability coding which yielded excellent interrater reliability for past year CUD criteria count, r ϭ .98, p Ͻ .001.
Cannabis use descriptives. High and low perceived DI groups were characterized by their cannabis use history, cannabis and other substance use frequency, and cannabis use reduction intentions for descriptive purposes, group matching, and the larger RCT's aims. Cannabis use history variables including typical method of administration and social context, number of prior serious quit attempts, and age at cannabis use initiation and onset of regular use were collected using the Marijuana Smoking History Questionnaire (Bonn-Miller & Zvolensky, 2009 ). Current cannabis use reduction intentions were measured with the Marijuana Ladder (Slavet et al., 2006) , a 10-item visual analog ranging from precontemplation to maintenance stages of change. Number of cannabis use days in the past 4 weeks was assessed with the Timeline Follow-Back (Hjorthøj, Hjorthøj, & Nordentoft, 2012) , and cannabis use motives were assessed with the Marijuana Motives Measure (Zvolensky et al., 2007) . Past year frequency of other substance use was also collected with the Drug Use Questionnaire (Hien & First, 1991) .
Procedure
After interested participants provided informed consent, they were screened for eligibility and CUD criteria were assessed. Eligible participants were asked to abstain from drug use for 24 hr prior to the baseline appointment and to refrain from nicotine/ caffeine use on the day of the appointment; upon arrival, selfreport was used to assess compliance and the appointment was rescheduled if the participant failed to abstain. In addition to demographic and substance use questionnaires, various measures of negative emotionality were also completed as part of the larger study. Following completion of the questionnaires, EEG recording was conducted in a dimly lit, sound-attenuated room. Stimuli were presented using a Dell OptiPlex 780 computer running E-Prime Version 2.0.8.90. Stimuli were presented on a 21" CRT color monitor at a viewing distance of 100 cm, subtending a visual angle of 3.5°. The recording session consisted of several different tasks, including the complex go/no-go task which was completed before and after the stress induction. Total recording time lasted between 1 hr and 1.5 hr. Participants in high and low perceived DI groups were run by the same research team through an identical protocol, with the only exception an autobiographical stressful experience writing task that high perceived DI participants completed immediately upon arrival to the lab as part of the larger RCT. All materials and procedures used in the current study were reviewed This document is copyrighted by the American Psychological Association or one of its allied publishers.
and approved by the Florida State University Institutional Review Board.
Complex Go/No-Go Task
This variant of the go/no-go task assesses response inhibition in the context of increased working memory demand, and has been found to activate right lateralized prefrontal-parietal circuits in addition to the regions recruited in go/no-go tasks with static no-go stimuli (i.e., pre-SMA, left fusiform gyrus; Simmonds, Pekar, & Mostofsky, 2008) . The task included seven blocks comprised of 18 go trials (75%) and six no-go trials (25%) for a total of 126 go trials and 42 no-go trials. A distinct set of letters presented in a randomized sequence was used for each block. Prior to the beginning of each block, instructions regarding what button to press for each letter were presented. Participants were required to press the corresponding button, either left or right, for each letter that was different than the previous letter (i.e., go trials). No-go trials, in which participants were required to withhold a response, were signaled by a two-letter repeat. No-go and go stimuli (i.e., the letters) were presented for 200 ms with a response window of 700 ms. Accuracy feedback was then presented for an additional 1,000 ms (i.e., green/yellow bar for correct/incorrect responses, respectively). Intertrial intervals were marked by a fixation cross presented on the center of the screen for a randomized duration between 500 ms and 1,000 ms. To operationalize response inhibition ability, the number of errors on no-go trials (i.e., commission errors) as well as d-prime were used as dependent variables. D-prime is a measure of sensitivity in the discrimination of target stimuli (i.e., go trials) relative to nontarget stimuli (i.e., no-go trials; Wickens, 2002) . D-prime was computed by subtracting z-transformed incorrect no-go trial percentage from z-transformed correct go trial percentage.
Stress Induction
The Mannheim Multicomponent Stress Test (MMST) is a 5-min computerized task that involves simultaneous stressors in five modalities: (a) cognitive (i.e., increasingly difficult mental arithmetic); (b) emotional (i.e., presentation of images characterized by negative valence/high arousal); (c) acoustic (i.e., increasingly loud, continuous white noise); and (d) motivational (i.e., loss of monetary reward for each mistake on the mental arithmetic task). The first minute of the task involves the introduction of loud, white noise and serial presentation of negative images depicting mutilation/violence, some of which repeat themselves; participants are asked to identify the repeated pictures with a mouse click. This was done to increase attention to the distracting negative pictures during the subsequent mental arithmetic portion of the task. For the remaining 4 min of the task, the white noise and negative pictures continue in the background, interspersed with occasional positively valenced pictures to reduce habituation to the negative images. During this 4-min period, participants complete the computerized paced auditory serial addition task (PASAT-C; Lejuez, Kahler, & Brown, 2003) , a task that involves increasingly difficult mental arithmetic and working memory updating. Participants begin the PASAT-C with $5 and are told that they will be awarded whatever money remains at the end of the task, but each error on the PASAT-C is punished by an aversive explosion noise and monetary loss of five cents. Before the task begins, participants complete one minute of practice on the PASAT-C in the absence of white noise, negative images, and threat of monetary loss to acquaint participants with the mental arithmetic demands of the PASAT-C. Prior to the 1 min of practice and immediately after the 5-min task, self-reported state negative affect was measured using the mean of five negative affect words (anxiety, frustration, irritability, difficulty concentrating, physical discomfort) scored on a 0 -100 VAS scale (prestressor: ␣ ϭ .88; poststressor: ␣ ϭ .89). Significant MMST-elicited stress reactivity across subjective (effect sizes: ds ϭ 1.32-4.1) and physiological indices (heart rate, skin conductance, cortisol effect sizes: ds ϭ 1.1-1.85, ds ϭ 0.7-1.7, d ϭ 0.6) has been observed in healthy samples (Cackowski et al., 2014; Reinhardt, Schmahl, Wüst, & Bohus, 2012) and individuals diagnosed with borderline personality disorder (Cackowski et al., 2014 ; subjective stress reactivity effect size: d ϭ 1.27; heart rate reactivity effect size: d ϭ 1.52).
Stimulus Delivery and EEG Measurement
ERP data were collected using a Dell OptiPlex 780 computer and Neuroscan Acquire software. Two 64-channel Neuroscan SynAmps RT amplifiers (gain setting: 2,010db in AC mode) and a BrainVision actiCap 64-channel cap were used to measure EEG responses (1000 Hz sampling rate, with an online analog bandpass filter of 0.05 Hz-100 Hz). The midline electrode AFz was used as the ground and FCz was used as an online reference electrode. Offline, the data were rereferenced to the averaged mastoids (electrodes TP9 and TP10). Horizontal electrooculogram (EOG) activity was recorded from electrodes placed lateral to the outer canthus of each eye, while vertical EOG activity was recorded from electrodes placed above and below the left eye. Electrodes were filled using high-chloride (10%) Abrasive Electrolyte-Gel (EasyCap). All impedance values were below 10 kohms throughout the recording session.
Data Preprocessing
Data were first downsampled to 250 Hz, then high-pass (0.1 Hz; ripple ϭ .05 dB, attenuation ϭ 80 dB) and low-pass (30 Hz; ripple ϭ .01 dB, attenuation ϭ 40 dB) FIR filters were applied. Given that FCz was the online reference, FCz data was regenerated offline using the average reference assumption. Data were rereferenced to the averaged mastoids and epochs locked to stimulus onset were defined using the full 1,700 ms trial length with a 200-ms prestimulus baseline correction. The Fully Automated Statistical Thresholding for EEG artifact Rejection algorithm (FASTER; Nolan, Whelan, & Reilly, 2010) , an EEGLAB plugin, was used for artifact detection and rejection (see online supplemental material for more detail on FASTER and artifact rejection descriptives). Of the 63 participants with high DI enrolled, five had pre-and/or poststressor data excluded for the following reasons: excessive drift (n ϭ 1), inadequate electrode contact (n ϭ 1), poor mastoid data (n ϭ 3). Of the 44 participants with low DI enrolled, five had pre-and/or poststressor data excluded for the following reasons: poor mastoid data (n ϭ 1), technical problems (n ϭ 4). Further, pre-and/or poststressor data in which task performance was at or below 50% (i.e., correct responses were at or below chance) on either go or no-go trials was excluded (high DI: n ϭ 7; This document is copyrighted by the American Psychological Association or one of its allied publishers.
low DI: n ϭ 0), leaving 59 participants with high DI and 41 participants with low DI that had available pre and/or poststressor data for ERP analyses. Sixty-one participants with high DI and 41 participants with low DI participants had available pre-and/or poststressor data for behavioral performance analyses. Data from correct trials were used to create trial-averaged no-go and go waveforms (see Figure S1 in the online supplemental material). Temporospatial principal components analysis (PCA) was used to extract latent N2 and P3a ERP components (Dien & Frishkoff, 2005) to minimize the influence of overlapping components. Thus, hypotheses were tested using the PCA-derived factor amplitudes rather than local peak amplitudes extracted from the scalp-recorded waveforms.
Temporospatial PCA
To isolate the latent N2 and P3a components, a temporospatial PCA was conducted using the ERP PCA toolkit, Version 2.63 (Dien, 2010) . In line with guidelines for conducting PCA on ERP data (Dien, 2010; Dien, Khoe, & Mangun, 2007; Dien, Spencer, & Donchin, 2003) , a temporal PCA was performed first to isolate consistent and dissociable temporal patterns of electrocortical activity occurring from Ϫ200 ms to 700 ms (i.e., start of prestimulus baseline period to the end of the response window). The temporal PCA uses the time points from each participant's average ERP as the variables, and participants, trial types (i.e., no-go vs. go), and recording sites are utilized as observations. Promax rotation was used, and 10 temporal factors were extracted after examination of the scree plot (Cattell, 1966) . For each temporal factor, factor scores were generated for every observation (i.e., observed voltages across each combination of participant, trial type, and recording site), reflecting the variance in the original data captured by that temporal factor. A subsequent spatial PCA was conducted for each of the 10 temporal factors to distinguish among ERP components with comparable time courses but distinct spatial distributions. For each spatial PCA, recording sites were used as the variables, and participants, trial types, and temporal factor scores were utilized as observations. Infomax rotation was used, and four spatial factors were extracted for all 10 temporal factors after examination of the averaged scree plot, resulting in 40 unique factor combinations. The covariance matrix and Kaiser normalization were used for each PCA. Of the 40 unique factor combinations extracted by the temporospatial PCA, 15 accounted for at least 1% of the total variance in the data. These 15 factors were converted into microvolt-scaled waveforms representing the portion of the original data accounted for by that factor by multiplying the factor loadings, scores, and their standard deviations (Dien et al., 2003) . In line with established guidelines (Dien, Beal, & Berg, 2005) , the time course and spatial distribution of each of the 15 factor waveforms were assessed for resemblance to the N2 and P3a components expected in go/no-go and related cognitive control tasks (see online supplemental material and Figure S2 for more detail on the PCA results).
Consistent with Macatee et al.'s (2018) PCA results, a frontalcentral positivity (TF3SF1; P250 factor) functionally and topographically comparable with the N2 was observed such that it was the earliest factor to differentiate trial type (go Ͼ no-go), occurred between 200 ms and 300ms, and was maximal at frontal-central sites. P250 factor amplitude was greater on go relative to no-go trials, suggesting that the apparent no-go negativity in the scalprecorded data was the result of relative suppression of P250 factor amplitude on no-go trials as opposed to an enhanced negativity on these trials. A central positivity (TF1SF1; P3a factor) sensitive to trial type (no-go Ͼ go) with a comparable time course and spatial distribution to the P3a was also observed. P250 and P3a factor amplitudes were generated for each participant using the peak values on go and no-go trials. P250 and P3a factor waveforms are displayed in Figure 1 .
Data Analytic Plan
Before testing the primary hypotheses, three initial analyses were conducted. First, group comparisons were run to confirm high perceived DI's expected association with greater cannabis use-related problems. Second, to ensure the MMST elicited stress, a RM-ANOVA was used to evaluate change in state negative affect from pre to poststressor. Finally, bivariate correlations between task performance variables and inhibition-related neurophysiological activity were conducted to inform functional interpretations of the P250 and P3a factors.
Due to unbalanced data (i.e., some participants did not have valid pre and poststressor data; see Data Preprocessing section for greater detail), mixed effects models rather than RM-ANOVAs were used to test primary study hypotheses due to these models' capacity to handle missing data and thus allow inclusion of all valid data points. Further, mixed effects models allow specification of the covariance structure of the repeated measures data, optimizing model fit. The intercept and all main and interaction terms were entered as fixed effects.
To test DI's moderating effect on the impact of acute stress on inhibition performance, stress (pre-vs. poststressor) and DI group were entered as within-subject and between-subjects factors, respectively. Number of commission errors was entered as the dependent variable and modeled as a count variable with a negative binomial distribution (covariance structure: unstructured); d-prime was entered as the dependent variable in a separate analysis and modeled as a continuous variable with a normal distribution (covariance structure: unstructured). The DI ϫ Stress interaction was examined to test DI's hypothesized deleterious impact on response inhibition performance during acute stress recovery. MPS and CUD criteria were entered as covariates in follow-up analyses to evaluate the robustness of any observed DI effects.
To test DI's moderating effect on the impact of acute stress on inhibition-related neural activity, P250 and P3a factor amplitudes were entered as the dependent variable and modeled with a normal distribution in separate analyses (covariance structure: toeplitz heterogeneous) for the N2 and P3a components, respectively. Stress and trial (no-go vs. go) were entered as within-subject factors and DI group was entered as a between-subjects factor. DI ϫ Stress ϫ Trial interactions were examined to test DI's hypothesized deleterious impact on stress-elicited inhibitionrelated modulation of neural activity. Significant DI effects were probed with pairwise comparisons. MPS and CUD criteria were entered as covariates in follow-up analyses to evaluate the robustness of any observed DI effects. Significant MPS/CUD effects were probed with multiple regression.
To test stress-elicited response inhibition task performance and inhibition-related modulation of neural activity as mediators of This document is copyrighted by the American Psychological Association or one of its allied publishers.
high DI's link with cannabis problems, the SPSS PROCESS macro was used (Model 4; 5,000 bootstrapped samples) to estimate bias-corrected 95% confidence intervals for the indirect effects of interest (Hayes, 2012) . In line with recommendations (Hayes & Cai, 2007) , heteroskedasticity-consistent standard error estimators were used in mediation analyses (HC3; Davidson-Mackinnon). MPS scores and past year CUD criteria count were entered as outcome variables in separate single mediator models. DI group was entered as the independent variable, poststressor response inhibition (i.e., inhibition performance, neural activity) was entered as the mediator, and prestressor response inhibition was entered as a covariate; significance of indirect effects of DI on cannabis problems via poststressor response inhibition was evaluated using 95% CIs. Pre-and poststressor inhibition-related modulation of N2 (i.e., ⌬P250 factor) and P3a (i.e., ⌬P3a factor) amplitudes were quantified by regressing no-go on go amplitudes and saving the unstandardized residuals such that more positive ⌬P250 factor and less positive ⌬P3a factor reflected greater blunting of the inhibition-related N2 and P3a components, respectively.
Results

DI Group Comparisons
As expected, cannabis users with high relative to low DI demonstrated significantly greater cannabis problems across multiple indices including lifetime number of serious quit attempts, pastmonth cannabis problem severity, and lifetime as well as past year CUD criteria (see Table 1 ).
1 CUD interviews revealed that 6.6% of the high DI group did not meet DSM-5 criteria for past year CUD, whereas 19.6%, 18.1%, and 55.7% met criteria for mild, moderate, and severe CUD, respectively. In the low DI group, 26.8% did not meet criteria for CUD, whereas 51.3%, 17.1%, and 4.8% met criteria for mild, moderate, and severe CUD, respectively. Thus, regular cannabis users with high DI were diagnosed with significantly greater rates of severe CUD, 2 (1, N ϭ 102) ϭ 27.77, p Ͻ .001, whereas the low DI group had significantly greater proportions of cannabis users with mild CUD, 2 (1, N ϭ 102) ϭ 11.15, p ϭ .001, and no CUD, 2 (1, N ϭ 102) ϭ 8.03, p ϭ .005. Cannabis users with high DI also reported significantly greater coping, conformity, social, and expansion cannabis use motives than cannabis users low in DI, though DI group accounted for more than four times the variance in coping compared to other motives. Cannabis users with high DI also reported significantly greater motivation to change their cannabis use relative to those with low DI. No significant group differences were observed in past year frequency of other substance use, past month cannabis Figure 1 . PCA-derived P250 and P3a factor waveforms for no-go and go trials at pre (left panels) and poststressor (right panels) in the high and low DI groups are presented above. Topographical maps of the P250 and P3a factor amplitudes for no-go and go trials at pre-and poststressor in the high and low DI groups are displayed on the bottom. Colorbar scales are in microvolts. See the online article for the color version of this figure.
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use frequency, typical cannabis use administration method/social context, age at cannabis use initiation, or age at onset of regular cannabis use. Groups did not differ in race/ethnicity or age, but a significantly greater proportion of females in the high DI group was found. Because of this significant group difference, sex was included as a covariate to ensure significant DI effects were not attributable to biological sex. See Table S2 in the online supplemental material for DI group means across all behavioral and neurophysiological variables.
Stress Induction Manipulation Check
To assess if the MMST successfully increased subjective negative affect, a RM-ANOVA was conducted. Stress was entered as a within-subject factor (i.e., pre-vs. poststressor) and DI was entered as a between-subjects factor. Mean self-reported negative affect was entered as the dependent variable. As expected, there was a significant main effect of stress, F(1, 100) ϭ 226.28, p Ͻ .001, such that state negative affect increased from pre-(M ϭ 21.0, SE ϭ 1.6) to poststressor (M ϭ 49.6, SE ϭ 2.2) in the combined sample. The DI ϫ Stress interaction was nonsignificant, F(1, 100) ϭ 2.99, p ϭ .087, indicating that DI group did not significantly moderate subjective stress reactivity. However, the main effect of DI was significant, F(1, 100) ϭ 66.52, p Ͻ .001, such that overall negative affect was significantly greater in cannabis users with high, M ϭ 48.9, SE ϭ 2.1, relative to low DI, M ϭ 21.7, SE ϭ 2.6.
Relations Between Response Inhibition Task Performance and Neural Activity
Exploratory correlational analyses were conducted between go/ no-go task performance indices and inhibition-related neural activity to confirm interpretation of blunted ⌬P250 factor and ⌬P3a factor as maladaptive with respect to response inhibition. Blunted ⌬P250 factor was associated with slowed go reaction time (RT) at pre-and poststressor (rs ϭ .39, .48, ps Ͻ .001), whereas ⌬P250 factor correlations with go errors, commission errors, and d-prime were nonsignificant (rs ϭ Ϫ.04 -.07, ps Ͼ .47). Blunted prestressor, r ϭ Ϫ.27, p ϭ .008 but not poststressor, r ϭ Ϫ.12, p ϭ .24 ⌬P3a factor was significantly associated with increased commission errors. ⌬P3a factor was nonsignificantly correlated with go errors and d-prime at both time points (rs ϭ Ϫ.16 -Ϫ.04, ps Ͼ .13). Thus, both components demonstrated some significant asso- Note. Ms, SDs, and F/ 2 tests of the DI group effect for demographics, substance use descriptives, and cannabis problems/motives are presented above; 2 tests are used for categorical variables (sex: male, female; race/ethnicity: Black, White, Hispanic, Asian, Other; Typical cannabis use method: joint, bowl, bong, one-hitter,v aporizer; Typical cannabis use social context; alone, 2-3 people, 4ϩ people). Other substance use descriptives ϭ typical use frequency in the past year (0 ϭ never,1 ϭ once, 2 ϭ monthly or less, 3 ϭ 2-4 times/month, 4 ϭ 2-3 times/week, 5 ϭ 4ϩ times/week); MPS ϭ Marijuana Problems Scale; CUD criteria ϭ # of Cannabis Use Disorder criteria met in the past year; Cannabis use motives ϭ marijuana motives measure subscales (mean response). Significant group differences are bolded. This document is copyrighted by the American Psychological Association or one of its allied publishers.
ciations with worse response inhibition task performance such that blunted ⌬P250 factor was associated with prolonged RT, consistent with the N2 component's role in premotor conflict-monitoring during action selection, and blunted prestressor ⌬P3a factor was related to greater difficulty inhibiting prepotent motor responses, consistent with the P3a component's role in motor inhibition finalization and its evaluation.
DI Moderation of the Impact of Acute Stress on Response Inhibition
Behavioral Performance 
Neurophysiology
P250 factor. For the P250 factor, the main effect of trial, F(1, 98.29) ϭ 12.18, p ϭ .001, and the Stress ϫ Trial, F(1, 100.31) ϭ 6.72, p ϭ .011, interaction were significant, whereas the stress main effect was nonsignificant, F(1, 103.06) ϭ 3.14, p ϭ .079. Amplitudes were significantly less positive on no-go relative to go trials at both time points (prestressor: Mdiff ϭ Ϫ0.89, SE ϭ 0.45, t(120.54) ϭ Ϫ2.00, p ϭ .048; poststressor: Mdiff ϭ Ϫ1.95, SE ϭ 0.46, t(111.41) ϭ Ϫ4.19, p Ͻ .001) in the combined sample, though the trial effect was significantly larger at poststressor. The DI main effect, F(1, 103.55) ϭ 0.66, p ϭ .42, DI ϫ Trial, F(1, 98.29) ϭ 0.33, p ϭ .57, and DI ϫ Stress, F(1, 103.06) ϭ 1.95, p ϭ .17, effects were all nonsignificant. As hypothesized, the DI ϫ Stress ϫ Trial interaction was significant, F(1, 100.31) ϭ 9.86, p ϭ .002, though the effect was opposite the direction expected such that no-go P250 factor amplitudes became significantly less positive from pre-(M ϭ 3.21, SE ϭ 0.73) to poststressor (M ϭ 1.20, SE ϭ 0.76) in the high, t(137.96) ϭ Ϫ3.95, p Ͻ .001, but not low DI group, t(134.74) ϭ 0.02, p ϭ .98; stressor-elicited change in P250 factor amplitude on go trials was nonsignificant for the high, t(122.74) ϭ Ϫ0.91, p ϭ .37, and low DI, t(120.05) ϭ 0.51, p ϭ .61, group. Contrary to predictions, overall prestressor P250 factor amplitude was nonsignificantly different across DI groups, t(107.14) ϭ 1.22, p ϭ .23.
Importantly, the DI ϫ Stress ϫ Trial interaction remained significant, F(1, 98.75) ϭ 9.73, p ϭ .002, after sex was included in the model; further, an exploratory Sex ϫ DI ϫ Stress ϫ Trial term was also nonsignificant, F(4, 114.26) ϭ 1.05, p ϭ .38. Similarly, when CUD criteria was included in the model, the DI ϫ Stress ϫ Trial interaction remained significant, F(1, 95.85) ϭ 10.72, p ϭ .001, whereas all CUD criteria main and interaction terms were nonsignificant, ps Ͼ .10.
2 When the MPS was included in the model, the DI ϫ Stress ϫ Trial interaction also remained significant, F(1, 95.53) ϭ 14.20, p Ͻ .001; further, the MPS ϫ Stress ϫ Trial interaction was significant, F(1, 99.42) ϭ 4.24, p ϭ .042, which revealed a DI-independent association between greater MPS scores and stress-elicited blunting of ⌬P250 factor, ␤ ϭ .29, t (85) Before assessing cannabis problem severity's association with ⌬P3a factor during acute stress recovery, DI effects were removed given their nonsignificance. In both the CUD criteria and MPS models, the three-way interaction terms were nonsignificant (ps Ͼ .30) and thus were removed from the models before examining cannabis problem severity main and two-way interaction effects. In the CUD criteria model, the CUD Criteria ϫ Trial interaction was significant, F(1, 113.61) ϭ 4.86, p ϭ .030, whereas the other CUD criteria effects were nonsignificant, psϾ.51. Similarly, in the MPS model, the MPS ϫ Trial interaction was marginal, F(1, 113.73) ϭ 3.26, p ϭ .074, whereas the other MPS effects were nonsignificant, ps Ͼ .45. Probing of both interactions re-2 Interestingly, the expected difference in overall P250 factor amplitude between high (M ϭ 3.90, SE ϭ 0.60) and low DI (M ϭ 1.83, SE ϭ 0.71) groups was significant, t(114.03) ϭ Ϫ2.10, p ϭ .038, when the CUD criteria main effect, F(1, 115.21) ϭ 4.61, p ϭ .034, was included in the model, which revealed a DI-independent inverse association between CUD criteria and overall P250 factor amplitude, ␤ ϭ Ϫ.22, t(86) ϭ Ϫ1.75, p ϭ .085. Thus, failure to replicate finding of a positive association between perceived DI and baseline P2 factor amplitude may have been due to the suppressive effects of CUD severity in the present study. This document is copyrighted by the American Psychological Association or one of its allied publishers.
vealed positive associations between cannabis problem severity and enhanced ⌬P3a factor (CUD criteria: ␤ ϭ .24, t(87) ϭ 2.27, p ϭ .026; MPS: ␤ ϭ .17, t(87) ϭ 1.62, p ϭ .11).
Evaluation of Stress-Elicited Response Inhibition as a Mediator of the Relationship Between DI and Cannabis Problem Severity
Given the nonsignificant associations between DI, behavioral performance, and the P3a, stress-elicited response inhibition as a mediator of the relationship between DI and cannabis problem severity was only evaluated for stress-elicited ⌬P250 factor.
The direct effects of DI on past-month cannabis problem severity, B ϭ 6.44, SE ϭ 0.78, t(85) ϭ 8.28, p Ͻ .001; and CUD criteria, B ϭ 3.01, SE ϭ 0.51, t(85) ϭ 5.91, p Ͻ .001, were significant. The direct effect of stress-elicited ⌬P250 factor on past-month cannabis problem severity was also significant, B ϭ 0.31, SE ϭ 0.11, t(85) ϭ 2.73, p ϭ .008, whereas it was nonsignificant for CUD criteria, B ϭ .10, SE ϭ 0.08, t(85) ϭ 1.32, p ϭ .19. Due to the inverse association between DI and stress-elicited ⌬P250 factor, B ϭ Ϫ2.25, SE ϭ 0.76, t(86) ϭ Ϫ2.97, p ϭ .004, together with the positive associations between past-month cannabis problem severity and stress-elicited ⌬P250 factor as well as DI, the significant indirect effect of DI on past-month cannabis problems via stress-elicited ⌬P250 factor was negative, B ϭ Ϫ.70, SE ϭ 0.33, 95% CI [Ϫ1.41, Ϫ0.15], indicating suppressor mediation. The indirect effect of DI on CUD criteria via stress-elicited ⌬P250 factor was nonsignificant, B ϭ Ϫ.22, SE ϭ 0.17, 95% CI [Ϫ0.57, 0.12] (see Table S3 in the online supplemental material).
Discussion
The present study sought to test the theorized role of stresselicited impairment of response inhibition as a mechanism underlying the relationship between high perceived DI and CUD. Although this mechanistic hypothesis was not supported at behavioral or neurophysiological units of analysis, stress-elicited blunting of ⌬N2 during response inhibition was associated with greater past-month cannabis problem severity independent of DI. Interestingly, significant suppressor mediation of perceived DI's relationship with past-month cannabis problems via stress-elicited ⌬N2 was found such that high perceived DI's link with stress-elicited enhancement of ⌬N2 reduced the positive association between high perceived DI and past-month cannabis problems. The significant suppressor mediation effect suggests that stress-elicited enhancement of conflict-monitoring during response inhibition may be a neurophysiological marker of resilience to cannabis problems among this high-risk group of cannabis users. In contrast to the ⌬N2, perceived DI's association with ⌬P3a was nonsignificant. However, enhanced ⌬P3a was positively related to cannabis problem severity regardless of acute stress, indicating that motor inhibition finalization-related processing may be a trait-like neural marker of cannabis problem severity among regular users. Overall, results do not support stress-elicited response inhibition impairment as a mechanism underlying the relationship between high perceived DI and CUD, but broad support was found for an association between greater cannabis problem severity and altered response inhibition-related neural activity in conjunction with intact response inhibition but impaired response initiation performance.
Independent of cannabis problem severity, high perceived DI was associated with stressor-elicited enhancement of conflictrelated processing during response inhibition such that inappropriate premotor response preparation during no-go trials (i.e., no-go P250 factor amplitude) was more effectively suppressed under stress relative to baseline. In contrast to some prior studies (Falkenstein, Hoormann, & Hohnsbein, 1999; Pliszka, Liotti, & Woldorff, 2000) but consistent with others (e.g., Jiang & Rau, 2017; , ⌬N2 was nonsignificantly associated with commission errors but was significantly, positively related to go RT, indicating that ⌬N2 reflects the degree to which early, premotor response preparation processes are appropriately modulated by current inhibition demand. Thus, the stress-elicited ⌬N2 enhancement observed in the high perceived DI group likely reflects a neural process that, given its association with faster go RT in the absence of worsened performance, is adaptive. Indeed, stress-elicited enhancement of the no-go N2 reduced high perceived DI's positive association with past-month cannabis problem severity and has also been observed in healthy samples (Dierolf et al., 2017; Qi et al., 2017) , suggesting that stress-elicited ⌬N2 enhancement may reflect adaptive adjustment of response conflict-monitoring systems in the face of increased environmental demands (e.g., acute stress). In contrast to the stress-elicited enhancement of ⌬N2 observed in the high perceived DI group, stress-elicited blunting of ⌬N2 was associated with greater past-month cannabis problem severity independently of perceived DI. This finding suggests that failure to demonstrate adaptive enhancement of conflict-related processing during acute stress recovery rather than trait conflict-related processing is a superior marker of past-month cannabis problem severity among regular users.
Although the overall prestressor N2 component was more positive in the high relative to low perceived DI group, the group difference was unexpectedly nonsignificant. This failure to replicate finding of a positive association between perceived DI and the baseline N2 component across trial types is likely due to sample differences. Substance use disorders were infrequent among Macatee et al.'s (2018) sample, whereas the present study's sample was comprised only of regular cannabis users, many of whom met criteria for a CUD. Indeed, when the main effect of CUD criteria was entered as a covariate in the mixed effects model testing DI's association with stress-elicited ⌬P250 factor (see Footnote 2), overall prestressor P250 factor amplitude was significantly more positive in high relative to low perceived DI users, consistent with hypotheses and Macatee et al.'s (2018) finding. Thus, high CUD severity may have suppressed the positive association between high perceived DI and P250 factor amplitude in the present study. Future research is needed to determine the conditions in which baseline inefficient conflict-related processing during a response inhibition task as indexed by the N2 component is a reliable neural correlate of perceived DI.
Contrary to hypotheses, enhanced rather than blunted ⌬P3a was positively associated with cannabis problem severity regardless of acute stress. Consistent with prior studies (e.g., Falkenstein et al., 1999; , enhanced prestressor ⌬P3a was significantly associated with decreased commission errors, making its association with greater cannabis problem severity counterintuitive. However, positive associations between cannabis use and cognitive control neural activity have been reported in prior work and interpreted as This document is copyrighted by the American Psychological Association or one of its allied publishers.
prefrontal inefficiency, possibly reflecting compensatory neural adaptations, utilization of inefficient task strategies, and/or increased task effort. (Aloi et al., 2018; Gruber, Dahlgren, Sagar, Gönenc, & Killgore, 2012; Gruber & Yurgelun-Todd, 2005; Hester et al., 2009; Smith et al., 2011; Tapert et al., 2007) . Consistent with this interpretation, greater cannabis problem severity was associated with increased errors on go trials regardless of acute stress, suggesting that enhanced ⌬P3a in disordered cannabis users may reflect compensatory activity to achieve normative response inhibition performance at the expense of response initiation performance. Given the absence of significant moderation by acute stress, enhanced ⌬P3a may be a trait-like neural marker of CUD severity in regular cannabis users, though blunted ⌬P3a in conjunction with slowed go RT among CUD patients relative to nonuser healthy controls has also been found (Maij et al., 2017) . Future studies should include a nonuser control group to determine the nature of ⌬P3a alterations across the cannabis use to CUD spectrum. The current study has several limitations. First, successful elicitation of acute stress was only assessed via self-reported negative affect measured immediately before and after the stressor. Although a robust increase in subjective negative affect from pre-to poststressor was observed, future studies should repeatedly measure both subjective and biological (e.g., cortisol) indicators of acute stress to better assess the time course of the stress response and its influence on subsequent cognitive control functioning. Second, participants always completed the prestressor go/no-go task prior to the poststressor go/no-go task to minimize variance from possible participant by task order interaction effects (e.g., via individual differences in stressor carry-over effects), leaving open the possibility that differences between pre-and poststressor go/no-go tasks were due to influences (e.g., fatigue, practice effects) other than acute stress. However, the enhancement of the N2 component in the high DI group as well as the blunting of the P2 (see online supplemental material) and no-go P3a components in the combined sample are generally consistent with the stressor-elicited changes in these components found in prior studies using counterbalanced designs (Dierolf et al., 2017; Qi et al., 2017) , supporting the interpretation that the ERP changes observed in the present study were attributable to acute stress. Nevertheless, future studies should use a control group to rule out alternative explanations. Third, the typical no-go Ͻ go trial effect on scalp-recorded N2 amplitude was not significant at prestressor, consistent with some prior studies using complex go/no-go tasks (Littel, Euser, Munafò, & Franken, 2012; Maij et al., 2017; Rietdijk, Franken, & Thurik, 2014) . Although PCA was used to enhance separation of ERP components and the trial effect on the extracted P250 factor was significant, it is possible that the P250 factor is not reflective of the typical N2 observed in simple go/no-go tasks, though the factor's properties suggest that it reflects some form of an action selection process related to response conflict resolution; nevertheless, future studies should also utilize simple go/no-go tasks to clarify the precise nature of DI and CUD-linked alterations in premotor inhibition-related neural activity. Fourth, future studies should assess for and exclude individuals with a history of neurological conditions that may affect response inhibition to rule out alternative explanations for the observed findings.
Overall, the current study's results provide further support for the role of perceived DI in demarcating CUD risk among regular cannabis users, but, contrary to the theorized importance of response inhibition functioning to DI (Trafton & Gifford, 2011) , no evidence of stress-elicited impairment in response inhibition as an underlying mechanism linking high perceived DI and CUD was found. Acute stress did affect inhibition-related neural activity at the action selection stage of processing among cannabis users with high perceived DI, but relations between neural activity, behavioral performance, and cannabis problem severity suggest that this effect was adaptive. Thus, the current study revealed null findings for one potential mechanism underlying the link between high perceived DI and CUD and suggests that other theoretically plausible mechanisms should be considered (e.g., . Finally, support was found for the sensitivity of neural but not behavioral indices of response inhibition to CUD severity, though more errors on go trials were found in individuals with greater cannabis problem severity. Cannabis users with greater problem severity demonstrated aberrant premotor conflictrelated processing during acute stress recovery and devoted greater cognitive resources to motor inhibition finalization regardless of acute stress. Given the absence of significant associations between cannabis problem severity and errors on no-go trials, observed associations with inhibition-related neural activity likely reflect compensatory neural adaptations and/or utilization of inefficient task strategies that normalize inhibition behavior at the expense of response initiation performance. To determine if these associations are etiologically relevant, future studies should employ prospective designs to determine if baseline and poststressor inhibition-related neural activity predicts change in cannabis problem severity over time among regular users.
